Found 6 matching trials
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus PHASE2 Primary Objective:
The primary objective of this study was to assess the d...
Show More Location
Investigational Site Number 8400028
Learn More & Join Trial
A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period PHASE1 Primary Objectives:
* Main study: To assess in overweight to obese subject...
Show More Location
Investigational Site Number 8400002
Learn More & Join Trial
Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease PHASE2 Primary Objective:
\- To evaluate the dose response relationship of SAR425...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects PHASE1 Primary Objective:
To assess in overweight to obese subjects the change in...
Show More Location
Investigational Site Number 8400001
Learn More & Join Trial
Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients PHASE1 Primary Objective:
To assess in healthy adult male subjects:
* The tolera...
Show More Location
Investigational Site Number 276001
Learn More & Join Trial
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients PHASE1 Primary Objectives:
To assess in overweight to obese T2DM patients:
* The...
Show More Location
Investigational Site Number 7520001
Learn More & Join Trial